What's Happening?
Lotte Biologics is set to unveil its new Songdo bio campus at the 2026 BIO International Convention in San Diego, California. Scheduled for completion in August, the Songdo Plant 1 will be introduced to global
clients for the first time. The company aims to expand its partnerships by showcasing its manufacturing capabilities, including large-scale production and customized solutions. Lotte Biologics plans to highlight its operational advantages, connecting its facilities in Syracuse, USA, and Songdo, Korea. The company will host presentations on collaboration strategies, manufacturing efficiency, and digitalization at its independent exhibition booth.
Why It's Important?
The unveiling of Lotte Biologics' Songdo Plant 1 marks a significant step in the company's expansion strategy. By participating in BIO USA, Lotte Biologics positions itself as a competitive player in the global biotechnology market. The new plant's capabilities are expected to enhance the company's contract development and manufacturing organization (CDMO) competitiveness. This development is crucial for Lotte Biologics as it seeks to strengthen its presence in North America and Asia, potentially leading to increased business opportunities and collaborations with global pharmaceutical and biotechnology companies.
